These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12894225)
1. p38 MAP kinase modulates Smad-dependent changes in human prostate cell adhesion. Hayes SA; Huang X; Kambhampati S; Platanias LC; Bergan RC Oncogene; 2003 Jul; 22(31):4841-50. PubMed ID: 12894225 [TBL] [Abstract][Full Text] [Related]
2. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Xu L; Chen S; Bergan RC Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects. Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268 [TBL] [Abstract][Full Text] [Related]
4. The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells. Fu Y; O'Connor LM; Shepherd TG; Nachtigal MW Biochem Biophys Res Commun; 2003 Oct; 310(2):391-7. PubMed ID: 14521923 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969 [TBL] [Abstract][Full Text] [Related]
6. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells. Buck MB; Pfizenmaier K; Knabbe C Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732 [TBL] [Abstract][Full Text] [Related]
7. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Nöth U; Tuli R; Seghatoleslami R; Howard M; Shah A; Hall DJ; Hickok NJ; Tuan RS Exp Cell Res; 2003 Nov; 291(1):201-11. PubMed ID: 14597420 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a role of MSK1 in transforming growth factor-beta-mediated responses through p38alpha and Smad signaling pathways. Abécassis L; Rogier E; Vazquez A; Atfi A; Bourgeade MF J Biol Chem; 2004 Jul; 279(29):30474-9. PubMed ID: 15133024 [TBL] [Abstract][Full Text] [Related]
9. Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts. Suzuki H; Uchida K; Nitta K; Nihei H Clin Exp Nephrol; 2004 Sep; 8(3):188-95. PubMed ID: 15480895 [TBL] [Abstract][Full Text] [Related]
10. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells. Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346 [TBL] [Abstract][Full Text] [Related]
11. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1. Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389 [TBL] [Abstract][Full Text] [Related]
12. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. Kamaraju AK; Roberts AB J Biol Chem; 2005 Jan; 280(2):1024-36. PubMed ID: 15520018 [TBL] [Abstract][Full Text] [Related]
13. Differentiation of human melanoma cells through p38 MAP kinase is associated with decreased retinoblastoma protein phosphorylation and cell cycle arrest. Smalley KS; Eisen TG Melanoma Res; 2002 Jun; 12(3):187-92. PubMed ID: 12140374 [TBL] [Abstract][Full Text] [Related]
14. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875 [TBL] [Abstract][Full Text] [Related]
16. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Saika S; Okada Y; Miyamoto T; Yamanaka O; Ohnishi Y; Ooshima A; Liu CY; Weng D; Kao WW Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):100-9. PubMed ID: 14691160 [TBL] [Abstract][Full Text] [Related]
17. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. Hayashida T; Decaestecker M; Schnaper HW FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052 [TBL] [Abstract][Full Text] [Related]
19. Rapid signalling by androgen receptor in prostate cancer cells. Peterziel H; Mink S; Schonert A; Becker M; Klocker H; Cato AC Oncogene; 1999 Nov; 18(46):6322-9. PubMed ID: 10597231 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells. Selvamurugan N; Fung Z; Partridge NC FEBS Lett; 2002 Dec; 532(1-2):31-5. PubMed ID: 12459458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]